A biochemical survey of schizophrenia.
D000588:Amines / Q000378:metabolism; D000661:Amphetamine / Q000378:metabolism; D000906:Antibodies; D000937:Antigen-Antibody Reactions; D000963:Antimetabolites; D001711:Biotransformation; D001796:Blood Protein Disorders; D001921:Brain / Q000276:immunology; D001923:Brain Chemistry; D050260:Carbohydrate Metabolism; D002570:Ceruloplasmin / Q000032:analysis; D003300:Copper / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D008635:Mescaline / Q000009:adverse effects; D008659:Metabolic Diseases / Q000150:complications; D008745:Methylation; D008967:Molecular Biology; D010627:Phenethylamines / Q000652:urine; D011618:Psychotic Disorders / Q000209:etiology; D012106:Research; D012559:Schizophrenia / Q000175:diagnosis / Q000201:enzymology / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism
D000588:Amines; D000906:Antibodies; D000963:Antimetabolites; D010627:Phenethylamines; D012701:Serotonin; D003300:Copper; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D002570:Ceruloplasmin; D008635:Mescaline; D004837:Epinephrine